Pharma Reviews: Sun Pharma climbs 2.5%; CLSA upgrades rating to 'buy'

CLSA says Indian pharma sector reported stable Q4 earnings on the back of stable US sales sequentially despite heightened pricing pressure, and ...
Read more: Sun Pharma climbs 2.5%; CLSA upgrades rating to 'buy'